BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27082863)

  • 1. Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study.
    El-Mallawany NK; Kamiyango W; Slone JS; Villiera J; Kovarik CL; Cox CM; Dittmer DP; Ahmed S; Schutze GE; Scheurer ME; Kazembe PN; Mehta PS
    PLoS One; 2016; 11(4):e0153335. PubMed ID: 27082863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple therapy of vincristine, bleomycin and etoposide for children with Kaposi sarcoma: Results of a study in Malawian children.
    Macken M; Dale H; Moyo D; Chakmata E; Depani S; Israels T; Niyrenda D; Bailey S; Chagaluka G; Molyneux EM
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28988435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the outcomes of HIV-infected persons receiving treatment for Kaposi sarcoma in Conakry-Guinea.
    Bekolo CE; Soumah MM; Tiemtore OW; Diallo A; Yuma JD; Di Stefano L; Metcalf C; Cisse M
    BMC Cancer; 2017 Dec; 17(1):806. PubMed ID: 29197357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana.
    Cox CM; El-Mallawany NK; Kabue M; Kovarik C; Schutze GE; Kazembe PN; Mehta PS
    Pediatr Blood Cancer; 2013 Aug; 60(8):1274-80. PubMed ID: 23487320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi.
    Herce ME; Kalanga N; Wroe EB; Keck JW; Chingoli F; Tengatenga L; Gopal S; Phiri A; Mailosi B; Bazile J; Beste JA; Elmore SN; Crocker JT; Rigodon J
    J Int AIDS Soc; 2015; 18(1):19929. PubMed ID: 26028156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy for AIDS-related and endemic African Kaposi's sarcoma in southern Africa.
    Stein ME; Lachter J; Spencer D; Bezwoda WR
    Int J Dermatol; 1995 Oct; 34(10):729-32. PubMed ID: 8537166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi's sarcoma in children: an open randomised trial of vincristine, oral etoposide and a combination of vincristine and bleomycin.
    Chagaluka G; Stanley C; Banda K; Depani S; Nijram'madzi J; Katangwe T; Israels T; Bailey S; Mukaka M; Molyneux E
    Eur J Cancer; 2014 May; 50(8):1472-81. PubMed ID: 24636877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Navigating the heterogeneous landscape of pediatric Kaposi sarcoma.
    Kamiyango W; Villiera J; Silverstein A; Peckham-Gregory E; Campbell LR; El-Mallawany NK
    Cancer Metastasis Rev; 2019 Dec; 38(4):749-758. PubMed ID: 31845111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma.
    Volkow P; Cesarman-Maus G; Garciadiego-Fossas P; Rojas-Marin E; Cornejo-Juárez P
    AIDS Res Ther; 2017 May; 14(1):30. PubMed ID: 28558783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes for children and adolescents with Kaposi sarcoma.
    Silverstein A; Kamiyango W; Villiera J; Peckham-Gregory EC; McAtee CL; Scheurer ME; Cox CM; Kovarik CL; Campbell LR; Allen CE; Mehta PS; Kazembe PN; Ozuah NW; El-Mallawany NK
    HIV Med; 2022 Feb; 23(2):197-203. PubMed ID: 34634187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world use of chemotherapy for Kaposi's sarcoma in a large community-based HIV primary care system in Kenya.
    Freeman EE; Busakhala N; Regan S; Asirwa FC; Wenger M; Seth D; Moon KC; Semeere A; Maurer T; Wools-Kaloustian K; Bassett I; Martin J
    BMC Cancer; 2020 Jan; 20(1):71. PubMed ID: 31996161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for treating life-threatening Kaposi sarcoma during pregnancy in HIV-positive women in low income countries.
    Bacha JM; El-Mallawany NK; Slone JS; Wilkinson JP; Mehta PS; Campbell LR
    Int J STD AIDS; 2020 Jul; 31(8):724-734. PubMed ID: 32493141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kaposi sarcoma in South African children.
    Stefan DC; Stones DK; Wainwright L; Newton R
    Pediatr Blood Cancer; 2011 Mar; 56(3):392-6. PubMed ID: 21225916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi sarcoma in HIV-seronegative children presenting to the paediatric oncology ward in The Queen Elizabeth Central Hospital, Blantyre, Malawi during 2002-2014.
    Mittermayer-Vassallo K; Banda K; Molyneux EM
    Trop Doct; 2016 Jul; 46(3):138-42. PubMed ID: 26620689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of highly active antiretroviral therapy versus highly active antiretroviral therapy and chemotherapy in therapy-naive patients with HIV-associated Kaposi sarcoma in South Africa.
    Mosam A; Shaik F; Uldrick TS; Esterhuizen T; Friedland GH; Scadden DT; Aboobaker J; Coovadia HM
    J Acquir Immune Defic Syndr; 2012 Jun; 60(2):150-7. PubMed ID: 22395672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kaposi's sarcoma: Good outcome with doxorubicin, bleomycin and vincristine sulphate (ABV) chemotherapy and highly active antiretroviral therapy.
    Hesseling PB; Katayi E; Wharin P; Bardin R; Kouya F; Palmer D; Glenn M; Kruger M
    S Afr Med J; 2017 Oct; 107(11):952-953. PubMed ID: 29262935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children.
    Gantt S; Kakuru A; Wald A; Walusansa V; Corey L; Casper C; Orem J
    Pediatr Blood Cancer; 2010 May; 54(5):670-4. PubMed ID: 20205254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of protease inhibitor-based highly active antiretroviral therapy on survival in HIV-associated advanced Kaposi's sarcoma patients treated with chemotherapy.
    Leitch H; Trudeau M; Routy JP
    HIV Clin Trials; 2003; 4(2):107-14. PubMed ID: 12671778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent clinical presentations and outcomes among children and adolescents with Kaposi sarcoma in Malawi and Tanzania.
    Campbell LR; Silverstein A; Peckham-Gregory E; Kamiyango W; Villiera J; McAtee CL; Bacha JM; Kovarik CL; Mehta PS; Chanroo T; Kapesa A; Malingoti B; Mzikamanda R; Ozuah NW; Allen CE; Scheurer ME; El-Mallawany NK
    HIV Med; 2023 Jun; 24(6):664-675. PubMed ID: 36627111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Kaposi sarcoma in children with HIV-1 infection.
    Anglemyer A; Agrawal AK; Rutherford GW
    Cochrane Database Syst Rev; 2014 Jan; (1):CD009826. PubMed ID: 24464843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.